日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia

IKZF1基因缺失导致B细胞前体急性淋巴细胞白血病对阿糖胞苷产生耐药性

Vervoort, Britt M T; Butler, Miriam; Grünewald, Kari J T; Schenau, Dorette S van Ingen; Tee, Trisha M; Lucas, Luc; Huitema, Alwin D R; Boer, Judith M; Bornhauser, Beat C; Bourquin, Jean-Pierre; Hoogerbrugge, Peter M; Van der Velden, Vincent H J; Kuiper, Roland P; Van der Meer, Laurens T; Van Leeuwen, Frank N

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

一名复发性混合表型急性白血病青少年患者接受达雷妥尤单抗和维奈托克联合治疗后达到分子完全缓解

Stanulla, Martin; Schewe, Denis M; Bornhauser, Beat; Bourquin, Jean-Pierre; Eckert, Cornelia; Eberl, Wolfgang; Wolf, Saskia; Wolf, Julian; Vogiatzi, Fotini; Bergmann, Anke K; Cario, Gunnar; Beier, Rita; Sauer, Martin; Kratz, Christian P; Maecker-Kolhoff, Britta

Spectroscopic disentanglement of the quantum states of highly excited Cu(2)

高激发态 Cu(2) 量子态的光谱解纠缠

Beck, M; Bornhauser, P; Visser, Bradley; Knopp, G; Bokhoven, J A van; Radi, P P

RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo

RNA干扰在体内能有效靶向由融合癌基因驱动的人类白血病。

Jyotsana, N; Sharma, A; Chaturvedi, A; Scherr, M; Kuchenbauer, F; Sajti, L; Barchanski, A; Lindner, R; Noyan, F; Sühs, K-W; Grote-Koska, D; Brand, K; Vornlocher, H-P; Stanulla, M; Bornhauser, B; Bourquin, J-P; Eder, M; Thol, F; Ganser, A; Humphries, R K; Ramsay, E; Cullis, P; Heuser, M

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

针对 AML 或 MDS 使用清髓性与减强度同种异体移植准备方案的结果相似

S M Luger, O Ringdén, M-J Zhang, W S Pérez, M R Bishop, M Bornhauser, C N Bredeson, M S Cairo, E A Copelan, R P Gale, S A Giralt, Z Gulbas, V Gupta, G A Hale, H M Lazarus, V A Lewis, M C Lill, P L McCarthy, D J Weisdorf, M A Pulsipher

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

针对 AML、CML 和骨髓发育不良症的全强度无关骨髓供体移植中 BU 和 CY 与 CY 和 TBI 的比较分析

J P Uberti, M-A Agovi, S Tarima, M Haagenson, S Gandham, C Anasetti, K S Baker, B J Bolwell, M Bornhauser, K W Chan, E Copelan, S M Davies, J Finke, G A Hale, C Kollman, P L McCarthy, V Ratanatharathorn, O Ringdén, D J Weisdorf, J D Rizzo